Bacterial lipopolysaccharide both renders resistant mice susceptible to mercury-induced autoimmunity and exacerbates such autoimmunity in susceptible mice

Clinical and Experimental Immunology

Volumn 141, Issue 2, 2005, Pages 238-247

  Abedi Valugerdi, Manuchehr ^a   Nilsson, C ^b   Zargari, A ^c   Gharibdoost, F ^d   Depierre, J W ^a   Hassan, M ^b  

^a STOCKHOLM UNIVERSITY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Autoimmunity; Innate immunity; Lipopolysaccharide; Mercuric chloride; Pro and non inflammatory cytokines

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CD4 ANTIGEN; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1; INTERLEUKIN 2; MERCURIC CHLORIDE; PHORBOL 13 ACETATE 12 MYRISTATE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; INNATE IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNITY; DISEASE SUSCEPTIBILITY; FEMALE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; KIDNEY; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MERCURIC CHLORIDE; MICE; MICE, INBRED DBA; MICE, INBRED STRAINS; SPLEEN; T-LYMPHOCYTES;

EID: 22344453973     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2005.02849.x     Document Type: Article

References (57)

1. Brickman CM, Shoenfeld Y. The mosaic of autoimmunity. Scand J Clin Lab Invest Suppl 2001; 235:3-15.
2. Luppi P, Rossiello MR, Faas S, Trucco M. Genetic background and environment contribute synergistically to the onset of autoimmune diseases. J Mol Med 1995; 73:381-93.
3. Mok CC, Lau CS. Pathogenesis of systemic lupus erythematosus. J Clin Pathol 2003; 56:481-90.
4. Zandman-Goddard G, Shoenfeld Y. SLE and infections. Clin Rev Allergy Immunol 2003; 25:29-40.
5. Adelman MK, Marchalonis JJ. Endogenous retroviruses in systemic lupus erythematosus: candidate lupus viruses. Clin Immunol 2002; 102:107-16.
6. Antonov D, Kazandjieva J, Etugov D, Gospodinov D, Tsankov N. Drug-induced lupus erythematosus. Clin Dermatol 2004; 22:157-66.
7. Di Luzio NR, Friedmann TJ. Bacterial endotoxins in the environment [Letter]. Nature 1973; 244:49-51.
8. Anderson WB, Slawson RM, Mayfield CI. A review of drinking-water- associated endotoxin, including potential routes of human exposure. Can J Microbiol 2002; 48:567-87.
9. van Deventer SJ, Knepper A, Landsman J et al. Endotoxins in portal blood. Hepatogastroenterology 1988; 35:223-5.
10. Heumann D, Roger T. Initial responses to endotoxins and Gram-negative bacteria. Clin Chim Acta 2002; 323:59-72.
11. Triantafilou M, Triantafilou K. Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster. Trends Immunol 2002; 23:301-4.
12. Kaisho T, Akira S. Toll-like receptors as adjuvant receptors. Biochim Biophys Acta 2002; 1589:1-13.
13. Moller G. Receptors for innate pathogen defence in insects are normal activation receptors for specific immune responses in mammals. Scand J Immunol 1999; 50:341-7.
14. Dziarski R. Preferential induction of autoantibody secretion in polyclonal activation by peptidoglycan and lipopolysaccharide. I. In vitro studies. J Immunol 1982; 128:1018-25.
15. Dziarski R. Preferential induction of autoantibody secretion in polyclonal activation by peptidoglycan and lipopolysaccharide. II. In vivo studies. J Immunol 1982; 128:1026-30.
16. Moller G. Lipopolysaccharide as a tool to reveal autoreactive B cells. APMIS 1988; 96:93-100.
17. Barton GM, Medzhitov R. Control of adaptive immune responses by Toll-like receptors. Curr Opin Immunol 2002; 14:380-3.
18. Dabbagh K, Lewis DB. Toll-like receptors and T-helper-1/T-helper-2 responses. Curr Opin Infect Dis 2003; 16:199-204.
19. Charreire J. Immune mechanisms in autoimmune thyroiditis. Adv Immunol 1989; 46:263-334.
20. Cavallo T, Granholm NA. Lipopolysaccharide from Gram-negative bacteria enhances polyclonal B cell activation and exacerbates nephritis in MRL/lpr mice. Clin Exp Immunol 1990; 82:515-21.
21. Granholm NA, Cavallo T. Long-lasting effects of bacterial lipopolysaccharide promote progression of lupus nephritis in NZB/W mice. Lupus 1994; 3:507-14.
22. Granholm NA, Cavallo T. Enhancement of renal disease in BXSB lupus prone mice after prior exposure to bacterial lipopolysaccharide. Lupus 1995; 4:339-47.
23. Sweet LI, Zelikoff JT. Toxicology and immunotoxicology of mercury: a comparative review in fish and humans. J Toxicol Environ Health B Crit Rev 2001; 4:161-205.
24. Moszczynski P. Mercury compounds and the immune system: a review. Int J Occup Med Environ Health 1997; 10:247-58.
25. Bagenstose LM, Salgame P, Monestier M. Murine mercury-induced autoimmunity: a model of chemically related autoimmunity in humans. Immunol Res 1999; 20:67-78.
26. Griem P, Gleichmann E. Metal ion induced autoimmunity. Curr Opin Immunol 1995; 7:831-8.
27. Enestrom S, Hultman P. Does amalgam affect the immune system? A controversial issue. Int Arch Allergy Immunol 1995; 106:180-203.
28. Borchers A, Ansari AA, Hsu T, Kono DH, Gershwin ME. The pathogenesis of autoimmunity in New Zealand mice. Semin Arthritis Rheum 2000; 29:385-99.
29. Izui S, Ibnou-Zekri N, Fossati-Jimack L, Iwamoto M. Lessons from BXSB and related mouse models. Int Rev Immunol 2000; 19:447-72.
30. Kotzin BL. Systemic lupus erythematosus. Cell 1996; 85:303-6.
31. Hultman P, Bell LJ, Enestrom S, Pollard KM. Murine susceptibility to mercury. I. Autoantibody profiles and systemic immune deposits in inbred, congenic, and intra-H-2 recombinant strains. Clin Immunol Immunopathol 1992; 65:98-109.
32. Hultman P, Bell LJ, Enestrom S, Pollard KM. Murine susceptibility to mercury. II. autoantibody profiles and renal immune deposits in hybrid, backcross, and H-2d congenic mice. Clin Immunol Immunopathol 1993; 68:9-20.
33. Abedi-Valugerdi M, Moller G. Contribution of H-2 and non-H-2 genes in the control of mercury-induced autoimmunity. Int Immunol 2000; 12:1425-30.
34. Abedi-Valugerdi M, Hansson M, Moller G. Genetic control of resistance to mercury-induced immune/autoimmune activation. Scand J Immunol 2001; 54:190-7.
35. Kono DH, Park MS, Szydlik A et al. Resistance to xenobiotic-induced autoimmunity maps to chromosome 1. J Immunol 2001; 167:2396-403.
36. Gronowicz E, Coutinho A, Melchers F. A plaque assay for all cells secreting Ig of a given type or class. Eur J Immunol 1976; 6:588-90.
37. al-Balaghi S, Moller E, Moller G, Abedi-Valugerdi M. Mercury induces polyclonal B cell activation, autoantibody production and renal immune complex deposits in young (NZB x NZW) F1 hybrids. Eur J Immunol 1996; 26:1519-26.
38. Hultman P, Johansson U, Dagnaes-Hansen F. Murine mercury-induced autoimmunity, the role of T-helper cells. J Autoimmun 1995; 8:809-23.
39. Mathieson PW, Thiru S, Oliveira DB. Mercuric chloride-treated brown Norway rats develop widespread tissue injury including necrotizing vasculitis. Lab Invest 1992; 67:121-9.
40. Waldner H, Collins M, Kuchroo VK. Activation of antigen-presenting cells by microbial products breaks self tolerance and induces autoimmune disease. J Clin Invest 2004; 113:990-7.
41. Vogel SN, Hilfiker ML, Caulfield MJ. Endotoxin-induced T lymphocyte proliferation. J Immunol 1983; 130:1774-9.
42. Caramalho I, Lopes-Carvalho T, Ostler D, Zelenay S, Haury M, Demengeot J. Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J Exp Med 2003; 197:403-11.
43. Tough DF, Sun S, Sprent J. T cell stimulation in vivo by lipopolysaccharide (LPS). J Exp Med 1997; 185:2089-94.
44. Castro A, Bemer V, Nobrega A, Coutinho A, Truffa-Bachi P. Administration to mouse of endotoxin from Gram-negative bacteria leads to activation and apoptosis of T lymphocytes. Eur J Immunol 1998; 28:488-95.
45. + T cells. J Immunol 1997; 159:591-8.
46. Jenkins MK, Khoruts A, Ingulli E et al. In vivo activation of antigen-specific CD4 T cells. Annu Rev Immunol 2001; 19:23-45.
47. Dutton RW, Bradley LM, Swain SL. T cell memory. Annu Rev Immunol 1998; 16:201-23.
48. Cerwenka A, Carter LL, Reome JB, Swain SL, Dutton RW. In vivo persistence of CD8 polarized T cell subsets producing type 1 or type 2 cytokines. J Immunol 1998; 161:97-105.
49. + T cells persist in vivo following induction of peripheral tolerance. J Immunol 1998; 160:4719-29.
50. Perez VL, Van Parijs L, Biuckians A, Zheng XX, Strom TB, Abbas AK. Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity 1997; 6:411-7.
51. Hamilton-Williams EE, Lang A, Benke D, Davey GM, Wiesmuller KH, Kurts C. Cutting edge: TLR ligands are not sufficient to break cross-tolerance to self-antigens. J Immunol 2005; 174:1159-63.
52. Biancone L, Andres G, Ahn H et al. Distinct regulatory roles of lymphocyte costimulatory pathways on T helper type-2 mediated autoimmune disease. J Exp Med 1996; 183:1473-81.
53. Bagenstose LM, Class R, Salgame P, Monestier M. B7-1 and B7-2 co-stimulatory molecules are required for mercury-induced autoimmunity. Clin Exp Immunol 2002; 127:12-9.
54. Pollard KM, Arnush M, Hultman P, Kono DH. Costimulation requirements of induced murine systemic autoimmune disease. J Immunol 2004; 173:5880-7.
55. Hoebe K, Janssen E, Beutler B. The interface between innate and adaptive immunity. Nat Immunol 2004; 5:971-4.
56. Hoebe K, Beutler B. LPS, dsRNA and the interferon bridge to adaptive immune responses: Trif, Tram, and other TIR adaptor proteins. J Endotoxin Res 2004; 10:130-6.
57. Hoebe K, Janssen EM, Kim SO et al. Upregulation of costimulatory molecules induced by lipopolysaccharide and double-stranded RNA occurs by Trif-dependent and Trif-independent pathways. Nat Immunol 2003; 4:1223-9.